uniQure (QURE) Cash from Financing Activities (2016 - 2026)

uniQure (QURE) recorded quarterly Cash from Financing Activities of $550000.0 in Q1 2026, down 77.54% quarter-over-quarter from $2.4 million in Q4 2025, and down 99.32% on a YoY basis from $80.7 million in Q1 2025.

uniQure (QURE) Cash from Financing Activities (2016 - 2026) Analysis & Trends

uniQure's Cash from Financing Activities history runs 11 years deep, the most recent figure standing at $550000.0 for Q1 2026.

  • In Q1 2026, Cash from Financing Activities fell 99.32% year-over-year to $550000.0; the TTM figure through Mar 2026 stood at $335.3 million (up 1482.99% YoY), while the FY2025 annual figure was $415.4 million, up 798.31% from the prior year.
  • Cash from Financing Activities was $550000.0 for Q1 2026 at uniQure, down from $2.4 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $370.1 million in Q2 2023 to a low of -$53.0 million in Q3 2024.
  • Historically, Cash from Financing Activities has averaged $48.0 million across 5 years, with a median of $301000.0 in 2022.
  • The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities surged 638067.24% in 2023, then sank 14267.39% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at $601000.0 in 2022, then plunged by 92.35% to $46000.0 in 2023, then tumbled by 14267.39% to -$6.5 million in 2024, then surged by 137.58% to $2.4 million in 2025, then plunged by 77.54% to $550000.0 in 2026.
  • The last three Cash from Financing Activities figures came in at $550000.0 (Q1 2026), $2.4 million (Q4 2025), and $332.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 7.00 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -600,000.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 53,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -538.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - 85,464.43
10 uniQure 2.88 Bn 2.88 Bn 3.34 Mn 550,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 550,000.00
Mar 31, 2026 550,000.00
Dec 31, 2025 2.45 Mn
Dec 31, 2025 2.45 Mn
Sep 30, 2025 332.24 Mn
Sep 30, 2025 332.24 Mn
Jun 30, 2025 44,000.00
Jun 30, 2025 44,000.00
Mar 31, 2025 80.67 Mn
Mar 31, 2025 80.67 Mn
Dec 31, 2024 -6.52 Mn
Dec 31, 2024 -6.52 Mn
Sep 30, 2024 -53.02 Mn
Sep 30, 2024 -53.02 Mn
Dec 31, 2023 46,000.00
Dec 31, 2023 46,000.00
Sep 30, 2023 -7.59 Mn
Sep 30, 2023 -7.59 Mn
Jun 30, 2023 370.14 Mn
Jun 30, 2023 370.14 Mn